Eye Drop Recall Info

From the AOA:
The New York Times  (2/2, Holpuch) reports Global Pharma, “the manufacturer of a brand of over-the-counter eye drops said that it was recalling the product, EzriCare Artificial Tears, after it was linked to a drug-resistant bacteria strain that has caused at least one person’s death and vision loss in five others.” The CDC “has advised people to stop using the eye drops, as the agency investigates an outbreak of a strain of the bacteria pseudomonas aeruginosa,” which “had never been identified in the United States before the current outbreak and is resistant to a class of antibiotics called carbapenems.”
        The Washington Post  (2/2, Ables) reports the CDC’s warning comes “after 55 patients in 12 states were identified with infections caused by a strain...between May and January.”
        The AP  (2/2, Stobbe) reports, “EzriCare, the company that markets the eye drops in the U.S., said it is not aware of any evidence definitively linking the outbreak to the product, but that it has stopped distributing the eye drops.”